GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
Author:
Publisher
Elsevier BV
Subject
Nephrology
Reference41 articles.
1. National Kidney Foundation. GFR decline as an endpoint in clinical trials for CKD. 2012. http://www.kidney.org/professionals/research/research_info.cfm. Accessed November 26, 2013.
2. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality;Coresh;JAMA,2014
3. GFR decline as an alternative end point to kidney failure in clinical trials: a meta-analysis of treatment effects from 37 randomized trials;Inker;Am J Kidney Dis,2014
4. GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials;Lambers Heerspink;Am J Kidney Dis,2014
5. Utility and validity of estimated GFR–based surrogate time-to-event end points in CKD: a simulation study;Greene;Am J Kidney Dis,2014
Cited by 420 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. New marker for chronic kidney disease progression and mortality in medical-word virtual space;Scientific Reports;2024-01-18
2. Timing of Initiation of Xanthine Oxidase Inhibitors Based on Serum Uric Acid Level Does Not Predict Renoprognosis in Patients with Preserved Kidney Function;Metabolic Syndrome and Related Disorders;2024-01-03
3. Empagliflozin in chronic kidney disease: nephroprotection is independent of albuminuria, primary kidney disease, and baseline eGFR;The Lancet Diabetes & Endocrinology;2024-01
4. Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial;The Lancet Diabetes & Endocrinology;2024-01
5. eGFR slope as a primary endpoint for clinical trials of CKD progression: one size fits all?;Clinical Kidney Journal;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3